Search filters

List of works by Jean-Marc Muller

A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.

scientific article published on 14 October 2015

A new cyclopamine glucuronide prodrug with improved kinetics of drug release

scientific article published on 31 October 2011

Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells.

scientific article published on January 1998

Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines

scientific article published on 01 January 1998

Anti-cell surface monoclonal antibodies which antagonize the action of VIP in a human adenocarcinoma cell line (HT 29 cells)

scientific article published on January 1, 1983

Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles.

scientific article published on January 2004

Atypical nuclear localization of VIP receptors in glioma cell lines and patients.

scientific article published on 30 October 2014

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

scientific article published in April 2003

Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach

scientific article published on 01 January 1986

Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).

scientific article published in September 1985

Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29)

scientific article published on 01 May 1986

Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice

scholarly article

Demonstration of molecular forms of Rap 1 in cells or tissues deriving from normal or pathological human colonic epithelium

scientific article published on January 1, 1995

Differential Expression and Function of PACAP and VIP Receptors in Four Human Colonic Adenocarcinoma Cell Lines

scientific article published on 01 January 1998

Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.

scientific article published on January 2003

Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors.

scientific article published on 4 October 2014

Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29).

scientific article published in June 1987

Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat.

scientific article published in July 2006

Functional vasoactive intestinal polypeptide (VIP) receptors in human neuroblastoma subclones that contain VIP precursor mRNA and release VIP-like substances

scientific article published on 01 March 1989

Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.

scientific article published in November 2004

HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.

scientific article

Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.

scientific article

Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29)

scientific article published in 1985

Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testis

scientific article

Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity

scientific article published on July 2006

Modification of HT 29 cell response to the vasoactive intestinal peptide (VIP) by membrane fluidization

scientific article published on 01 December 1985

Molecular characteristics and peptide specificity of bradykinin binding sites in intact neuroblastoma-glioma cells in culture (NG 108-15).

scientific article published in July 1989

Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal

scientific article

Monensin and tunicamycin-induced inhibition of HT29 cell spreading and growth

scientific article published in February 1986

Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins

scientific article published on February 2004

Neuropeptides of the VIP family inhibit glioblastoma cell invasion.

scientific article published on 7 January 2015

New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers

scientific article

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP

scientific article published on 21 January 2019

Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy

scientific article published on January 2007

Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogs

scientific article published in January 1996

Proliferative actions of natriuretic peptides on neuroblastoma cells. Involvement of guanylyl cyclase and non-guanylyl cyclase pathways

scientific article

Retinoic acid enhances VIP receptor expression and responsiveness in human neuroblastoma cell, SH-SY5Y.

scientific article published in July 1989

Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines.

scientific article published on January 1997

Signaling pathways in breast cancer: therapeutic targeting of the microenvironment

scientific article published on 03 August 2014

Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells

scientific article published on 01 August 1996

The VIP-receptor system in neuroblastoma cells

scientific article published on 20 September 2006

The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes

scientific article

The small G-proteins Rap 1 as potential targets of vasoactive intestinal peptide effects in the human clonic cancer cells HT29.

scientific article published on December 1998

The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migration

scientific article

Un neuropeptide à l’origine du vieillissement testiculaire ?

scientific article published on 01 October 2006

Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update

scientific article published on 19 April 2007

VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells

scientific article published on 27 January 2016

VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment

scientific article published on April 1, 1995

Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.

scientific article published on November 2008

Vasoactive intestinal peptide stimulates proliferation in HT29 human colonic adenocarcinoma cells: concomitant activation of Ras/Rap1-B-Raf-ERK signalling pathway

scientific article published in April 2003

Vasoactive intestinal peptide-induced neurite remodeling in human neuroblastoma SH-SY5Y cells implicates the Cdc42 GTPase and is independent of Ras-ERK pathway

scientific article published on October 2004

Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25.

scientific article